David L. Hallal's most recent trade in Scholar Rock Holding Corp was a trade of 18,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 27, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Scholar Rock Holding Corp | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
Scholar Rock Holding Corp | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 304,095 (1%) | 0% | 0 | Common Stock | |
Seer Inc - Ordinary Shares... | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 58,178 | 355,128 | - | 0 | Class A Common Stock | |
ITeos Therapeutics Inc | David L. Hallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 24,200 | 24,200 | - | - | Stock Option (Right to Buy) | |
Kalaris Therapeutics Inc. | David L. Hallal | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 2,143,662 | - | 0 | Common Stock |